These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38370154)

  • 1. Predictors of left ventricular ejection fraction in high-risk percutaneous coronary interventions.
    Panoulas VF; Escaned J; Hill JM; Barker E; Butler K; Almedhychy A; Tsintzos SI; O'Neill WW
    Front Cardiovasc Med; 2024; 11():1342409. PubMed ID: 38370154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes in patients undergoing complex, high-risk percutaneous coronary intervention and haemodynamic support with intra-aortic balloon versus Impella pump: Real-life single-centre preliminary results.
    Januszek R; Pawlik A; Rzeszutko Ł; Bartuś K; Bartuś S
    Kardiol Pol; 2022; 80(12):1224-1231. PubMed ID: 36047958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of in-Hospital Left Ventricular Ejection Fraction Recovery on Long-Term Outcomes in Patients Who Underwent Impella Support for HR PCI or Cardiogenic Shock: A Sub-Analysis from the IMP-IT Registry.
    Iannaccone M; Franchin L; Burzotta F; Botti G; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Masiero G; Di Biasi M; Pagnotta P; Casu G; Scandroglio AM; Tarantini G; Chieffo A
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37240996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry.
    Burzotta F; Russo G; Ribichini F; Piccoli A; D'Amario D; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Crea F; Trani C
    J Interv Cardiol; 2019; 2019():5243913. PubMed ID: 31772533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction.
    Marin F; Pighi M; Zucchelli F; Ruzzarin A; Russo G; Aurigemma C; Romagnoli E; Ferrero V; Piccoli A; Scarsini R; Pesarini G; Trani C; Burzotta F; Ribichini FL
    J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study.
    Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E;
    Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.
    Romagnoli E; Burzotta F; Cerracchio E; Russo G; Aurigemma C; Pedicino D; Locorotondo G; Graziani F; Leone AM; D'Amario D; Lombardo A; Malara S; Fulco L; Bianchini F; Sanna T; Trani C
    Int J Cardiol; 2023 Sep; 387():131098. PubMed ID: 37290663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Javaid AI; Michalek JE; Gruslova AB; Hoskins SA; Ahsan CH; Feldman MD
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):30-41. PubMed ID: 37997292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Kuno T; Takagi H; Ando T; Kodaira M; Numasawa Y; Fox J; Bangalore S
    Catheter Cardiovasc Interv; 2021 Apr; 97(5):E636-E645. PubMed ID: 32894797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
    Dangas GD; Kini AS; Sharma SK; Henriques JP; Claessen BE; Dixon SR; Massaro JM; Palacios I; Popma JJ; Ohman M; Stone GW; O'Neill WW
    Am J Cardiol; 2014 Jan; 113(2):222-8. PubMed ID: 24527505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis.
    Lansky AJ; Tirziu D; Moses JW; Pietras C; Ohman EM; O'Neill WW; Ekono MM; Grines CL; Parise H
    Am J Cardiol; 2022 Dec; 185():29-36. PubMed ID: 36210212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Tarantini G; Masiero G; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Mojoli M; Casu G; Giustino G; Lorenzoni G; Montorfano M; Ancona MB; Pappalardo F; Chieffo A;
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E222-E234. PubMed ID: 33793051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Ventricular Assist Devices: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(2):1-97. PubMed ID: 28232854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Healthcare Resource Utilization of Percutaneous Mechanical Circulatory Support Using Impella Versus Intra-aortic Balloon Pump Use for Patients With Acute Coronary Syndrome and Cardiogenic Shock Undergoing Percutaneous Coronary Interventions: Insights From National Inpatient Sample.
    Dodoo SN; Kwapong YA; Agyemang-Sarpong A; Amoran E; Egolum UO; Ghasemzadeh N; Ramadan R; Henry G; Samady H
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102053. PubMed ID: 37640173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial.
    Kovacic JC; Kini A; Banerjee S; Dangas G; Massaro J; Mehran R; Popma J; O'Neill WW; Sharma SK
    J Interv Cardiol; 2015 Feb; 28(1):32-40. PubMed ID: 25689546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.